Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures

Journal of Neuroscience

Volumn 16, Issue 14, 1996, Pages 4322-4334

  Shen, Maoxing ^a   Piser, Timothy M ^a,b   Seybold, Virginia S ^a   Thayer, Stanley A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

cannabinoid; G protein; glutamate; hippocampal culture; indo 1; intracellular calcium; patch clamp; presynaptic inhibition

Indexed keywords

CANNABINOID DERIVATIVE; CANNABINOID RECEPTOR; DRONABINOL;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

EID: 0029937282     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-14-04322.1996     Document Type: Article

References (80)

1. Abele AE, Scholz KP, Scholz WK, Miller RJ (1990) Excitotoxicity induced by enhanced excitatory neurotransmission in cultured hippocampal pyramidal neurons. Neuron 4:A413-A419.
2. Abood ME, Martin BR (1992) Neurobiology of marijuana abuse. Trends Pharmacol Sci 13:201-206.
3. 2+ influx. Br J Pharmacol 98:225-235.
4. Audette CA, Burstein SH, Doyle SA, Hunter SA (1991) G-protein mediation of cannabinoid-induced phospholipase activation. Pharmacol Biochem Behav 40:559-563.
5. Bell MR, D'Ambra TE, Kumar V, Eissenstat MA, Herrmann JU, Wetzel JR, Rosi D, Philion RE, Daum SJ, Hlasta DJ, Kullnig RK, Ackerman JH, Haubrich DR, Luttinger DA, Baizman ER, Miller MS, Ward SJ (1991) Antinociceptive (aminoalkyl)indoles. J Med Chem 34:1099-1110.
6. Bidaut-Russell M, Devane WA, Howlett AC (1990) Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain. J Neurochem 55:21-26.
7. Caulfield MP, Brown DA (1992) Cannabinoid receptor agonists inhibit Ca current in NG108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism. Br J Pharmacol 106:231-232.
8. Chen HSV, Pellegrini JW, Aggarwal SK, Lei SZ, Warach S, Jensen FE, Lipton SA (1992) Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor mediated neurotoxicity. J Neurosci 12:4427-4436.
9. Childers SR, Fleming L, Konkoy C, Marckel D, Pacheco M, Sexton T, Ward S (1992) Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain. Ann NY Acad Sci 654:33-51.
10. Collins DR, Pertwee RG, Davies SN (1994) The action of synthetic cannabinoids on the induction of long-term potentiation in the rat hippocampal slice. Eur J Pharmacol 259:R7-R8.
11. Compton DR, Gold L, Ward SJ, Balster R, Martin BR (1992) Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from (delta)9-tetrahydrocannabinol. J Pharmacol Exp Ther 263:1118-1126.
12. Compton DR, Rice KC, de Costa BR, Razdan RK, Melvin LS, Johnson MR, Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265:218-226.
13. D'Ambra TE, Estep KG, Bell MR, Eissenstat MA, Josef KA, Ward SJ, Haycock DA, Baizman ER, Casiano FM, Begun NC, Chippari SM, Grego JD, Kullnig RK, Daley GT (1992) Conformationally restrained analogues of pravadoline: nanomolar potent, enantioselective, (amino-alkyl)indole agonists of the cannabinoid receptor. J Med Chem 35:124-135.
14. Deadwyler SA, Hampson RE, Bennett BA, Edwards TA, Mu J, Pacheco MA, Ward SJ, Childers SR (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1:121-134.
15. De Lean A, Munson PJ, Rodbard D (1978) Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol 235:E97-E102.
16. Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796.
17. Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AS (1988) Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34:605-613.
18. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949.
19. Dimarzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686-691.
20. Faber DS, Korn H (1991) Applicability of the coefficient of variation method for analyzing synaptic plasticity. Biophys J 60:1268-1294.
21. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90:7656-7660.
22. 9-tetrahydracannabinol. J Pharmacol Exp Ther 272:699-707.
23. Glass M, Faull R, Dragunow M (1993) Loss of cannabinoid receptors in the substantia nigra in Huntington's disease. Neuroscience 56:523-527.
24. Grynkiewicz G, Peonie M, Tsien RY (1985) A new generation of calcium indicators with greatly improved fluorescence properties. J Biol Chem 260:3440-3450.
25. Harris RA, Stokes JA (1982) Cannabinoids inhibit calcium uptake by brain synaptosomes. J Neurosci 2:443-447.
26. Henry DJ, Chavkin C (1995) Activation of inwardly rectifying potassium channels (GIRK1) by co-expressed rat brain cannabinoid receptors in Xenopus oocytes. Neurosci Lett 186:91-94.
27. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci USA 87:1932-1936.
28. Herkenham M, Lynn AB, de Costa BR, Richfield EK (1991) Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res 547:267-274.
29. Hillard C, Edgemond W, Campbell W (1995) Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method - application to anandamide. J Neurochem 64:677-683.
30. Howlett A (1995) Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35:607-634.
31. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol Pharmacol 29:307-313.
32. Howlett AC, Johnson MR, Melvin LS, Milne GM (1988) Nonclassical Cannabinoids analgetics inhibit adenylate cyclase: development of a cannabinoid receptor model. Mol Pharmacol 33:297-302.
33. Jansen EM, Haycock DA, Ward SJ, Seybold VS (1992) Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res 575:93-102.
34. Johnson MR, Melvin LS (1986) The discovery of nonclassical cannabinoid analgetics. In: Cannabinoids as therapeutic agents (Mechoulam R, ed), pp 121-145. Boca Raton, FL: CRC.
35. 2+ concentration in isolated hippocampal neurons. Br J Pharmacol 89:191-198.
36. Kuster JE, Stevenson JI, Ward SJ, D'Ambra TE, Haycock DA (1993) Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic Cannabinoids. J Pharmacol Exp Ther 264:1352-1363.
37. Luebke JI, Dunlap K, Turner TJ (1993) Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron 11:895-902.
38. Mackie K, Hille B (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc Natl Acad Sci USA 89:3825-3829.
39. Mackie K, Devane WA, Hille B (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. Mol Pharmacol 44:498-503.
40. Mackie K, Lai Y, Westenbroek R, Mitchell R (1995) Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor. J Neurosci 15:6552-6561.
41. Mailleux P, Vanderhaeghen J (1992) Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry. Neuroscience 48:655-668.
42. Martin BR, Welch SP, Abood M (1994) Progress toward understanding the cannabinoid receptor and its second messenger systems. Adv Pharmacol 25:341-397.
43. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564.
44. Matsuda LA, Bonner TL, Lolait SJ (1993) Localization of cannabinoid receptor mRNA in rat brain. J Comp Neurol 327:535-550.
45. Mechoulam R, Hanus L, Martin BR (1994) Search for endogenous ligands of the cannabinoid receptor. Biochem Pharmacol 48:1537-1544.
46. Miller AS, Walker JM (1995) Effects of a cannabinoid on spontaneous and evoked neuronal activity in the substantia nigra pars reticulata. Eur J Pharmacol 279:179-185.
47. Munro S, Thomas K, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for Cannabinoids. Nature 365:61-65.
48. Nowicky AV, Teyler TJ, Vardaris RM (1987) The modulation of long-term potentiation by delta-9-tetrahydrocannabinol in the rat hippocampus. Brain Res Bull 19:663-672.
49. 3H]-5′-trimethylammonium delta 8-tetrahydrocannabinol. J Pharmacol Exp Ther 234:784-791.
50. 2+ fluorometry. Neurosci Lett 78:69-74.
51. 2+ concentration in rats. Neurosci Lett 140:55-58.
52. Orrego F, Villanueva S (1993) The chemical nature of the main central excitatory transmitter: a critical appraisal based upon release studies and synaptic vesicle localization. Neuroscience 56:539-555.
53. 2+ channels in a neuronal expression system. Mol Pharmacol 49:707-714.
54. Pertwee RG, Stevenson LA, Elrick DB, Mechoulam R, Corbett AD (1992) Inhibitory effects of certain enantiomeric Cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine. Br J Pharmacol 105:980-984.
55. Pertwee RG, Fernando SR, Griffin G, Abadji V, Makriyannis A (1995) Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. Eur J Pharmacol 272:73-78.
56. Piercey M, Hoffmann W, Kaczkofsky P (1988) Functional evidence for PCP-like effects of the anti-stroke candidate MK-801. Psychopharmacology 96:561-562.
57. Piser TM, Lampe RA, Keith RA, Thayer SA (1995) Complete and reversible block by ω-grammotoxin SIA of glutamatergic synaptic transmission between cultured rat hippocampal neurons. Neurosci Lett 201:1-4.
58. Robinson HPC, Kawahara M, Jimbo Y, Torimitsu K, Kuroda Y, Kawana A (1993) Periodic synchronized bursting and intracellular calcium transients elicited by low magnesium in cultured cortical neurons. J Neurophysiol 70:1606-1616.
59. Rose K, Christine C, Choi D (1990) Magnesium removal induces paroxysmal neuronal firing and NMDA receptor-mediated neuronal degeneration in cortical cultures. Neurosci Lett 115:313-317.
60. Roth S (1978) Stereospecific presynaptic inhibitory effect of delta-9-tetrahydrocannabinol on cholinergic transmission in the myenteric plexus of the guinea pig. Can J Physiol Pharmacol 56:968-975.
61. Sayer RJ, Redman SJ, Andersen P (1989) Amplitude fluctuations in small EPSPs recorded from CAl pyramidal cells in the guinea pig hippocampal slice. J Neurosci 9:840-850.
62. Scanziani M, Capogna M, Gahwiler BH, Thompson SM (1992) Presynaptic inhibition of miniature excitatory synaptic currents by baclofen and adenosine in the hippocampus. Neuron 9:919-927.
63. 2+ currents and synaptic transmission in cultured rat hippocampal pyramidal neurons. J Physiol (Lond) 435:373-393.
64. Scholz KP, Miller RJ (1995) Developmental changes in presynaptic calcium channels coupled to glutamate release in cultured rat hippocampal neurons. J Neurosci 15:4612-4617.
65. Seeburg PH (1993) The Trends Neurosci/TIPS lecture - the molecular biology of mammalian glutamate receptor channels. Trends Neurosci 16:359-365.
66. Shire D, Carillon C, Kaghad M, Calandra B, Rinaldicarmona M (1995) An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing. J Biol Chem 270:3726-3731.
67. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227.
68. Song ZH, Bonner TI (1995) A lysine residue of the cannabinoid receptor is critical for receptor recognition by several agonists but not WIN55212-2. Soc Neurosci Abstr 21:2060.
69. Spruston N, Jaffe DB, Williams SH, Johnston D (1993) Voltage- and space-clamp errors associated with the measurement of electrotonically remote synaptic events. J Neurophysiol 70:781-802.
70. 2+ transients using simultaneous microfluorimetry and electrophysiology. Pflügers Arch 412:216-223.
71. 9-THC-DMH. J Pharmacol Exp Ther 263:1383-1390.
72. Thompson SM, Capogna M, Scanziani M (1993) Presynaptic inhibition in the hippocampus. Trends Neurosci 16:222-227.
73. Tricklebank M, Singh L, Oles R, Preston C, Iversen S (1989) The behavioral effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor. Eur J Pharmacol 167:127-135.
74. Turkanis SA, Partlow LM, Karler R (1991) Delta-9-tetrahydrocannabinol depresses inward sodium current in mouse neuroblastoma cells. Neuropharmacology 30:73-77.
75. Ulrich D, Huguenard JR (1995) Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity. Neuron 15:909-918.
76. 2+ loads. J Neurophysiol 72:2563-2569.
77. Weinroth SE, Parenti DM, Simon GL (1995) Wasting syndrome in AIDS: pathophysiologic mechanisms and therapeutic approaches. Infect Agent Dis 4:76-94.
78. Werth JL, Thayer SA (1994) Mitochondria buffer physiological calcium loads in cultured rat dorsal root ganglion neurons. J Neurosci 14:348-356.
79. 2+ channels in supporting hippocampal synaptic transmission. Science 264:107-111.
80. B autoreceptor activation. J Neurosci 14:1775-1788.